Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin 1 in Recurrent/Refractory Hodgkin's Disease
NCT00003936Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jun 1999
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in Hodgkin lymphoma (HL), sponsored by Barbara Ann Karmanos Cancer Institute. Started Jun 1999; status: completed.
02
Drugs
bryostatin-1
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00003936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003936.